
Uvax Bio
Operator of a biotechnology company intended to create nanoparticle vaccine through antigen design. The company's platform develops and commercializes B-cell-focused, rapid antibody-eliciting vaccines...
Valuation
$0
Share Price
N/A
Total Raised
$23.6M
Last Round
N/A